Since our inception in 1997, Ergomed has rapidly grown to over 700 globally spread staff that provide unique expertise in clinical development / trial management.  While experienced in a wide variety of indications, Ergomed specializes in the fields of Orphan Drugs, Oncology/Haematology, Neurology/CNS, and Allergy/Immunology.

Executive Management Team

Dr Gordana Tonković

Head of Clinical Development

Dr Gordana Tonković

Head of Clinical Development

Dr Gordana Tonkovic has been with Ergomed since 2000, and she is Ergomed’s Head of Clinical Development. In this position Gordana provides leadership and vision for the entire organization and she plays a critical role in providing medical, scientific input to our clients. Gordana is a graduate of the University of Zagreb, where she obtained her Doctor of Medicine specialised in Neurology.

Sladana Sturlic

Head of Clinical Operations

Sladana Sturlic

Head of Clinical Operations

Sladana Sturlic currently serves as Ergomed’s Head of Clinical Operations. Sladana is one of Ergomed’s earliest employees and has been with the organization since September 1999 and has nearly 20 years of experience in clinical research, focusing on neurology, oncology, haematology, endocrinology, rheumatoid arthritis psychiatry and immunotherapy. She has worked in multiple roles within the organization each of which were within the clinical operations department. Prior to starting at Ergomed, Sladana was a Nurse for over seven years at the Clinical Hospital Center Zagreb and she has a BSc Degree in Entrepreneurship Economics from Vern’ University of Applied Sciences.

Dr Roger Legtenberg

Chief Executive Officer - PSR

Dr Roger Legtenberg

Chief Executive Officer - PSR

Dr Roger Legtenberg is the Chief Executive Officer of PSR Orphan Experts and PSR Pharma Resource, which is Ergomed’s orphan drug subsidiary. Roger has nearly twenty years of CRO experience with the last eight years CEO establishing significant progress and growth focusing on the ‘why’ in Rare Diseases. Roger is a frequent speaker and event organizer on rare disease focused events and he is also a member of the board for ACRON, the Advice Center Orphan Drugs and Rare Diseases and also served as member of the board for Biofarmind. Roger has a PhD in Medical Sciences from University Medical Center Nijmegen.

Dr Hans-Peter Hucke

Global Head of Data Management and Biostatistics

Dr Hans-Peter Hucke

Global Head of Data Management and Biostatistics

Hans-Peter Hucke holds a PhD in Statistics from the University of North Carolina at Chapel Hill. Since 1989 he has served as a statistician in different leading positions in clinical research and contributed to more than 150 clinical studies in various phases and indications. He joined Ergomed in 2016 and currently serves as Global Head of Data Management and Biostatistics.

Dr Alex Artyomenko

Head of RWE and Late Phase Division

Dr Alex Artyomenko

Head of RWE and Late Phase Division

Dr. Alex Artyomenko currently serves as the Head of Real-World Evidence and Late Phase department for Ergomed, and has been in this position since February 2017. Initially trained as a cardiologist, Alex managed acute care for ICU patients prior to joining the research field. Alex has over 15 years of clinical research experience, and has been involved in developing and implementing study designs and operational strategies for global studies and programs, involving many types of observational studies and therapeutic indications. He is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), focusing on improving standards for observational research, and helping the companies to strengthen the value of their products through Real-World Evidence.

Dr Thomas Portele

Head of Global Project Management and Monitoring

Dr Thomas Portele

Head of Global Project Management and Monitoring

Dr Thomas Portele is the Head of Global Project Management and Monitoring, a position that he has held since January 2017 and is the Head of our Frankfurt office. Thomas has over 20 years of experience in the clinical research space, including pre-clinical development through Phase IV trials with special emphasis on phase II and III trials. Thomas has experience in various indications, but has focused on Neurology and Oncology, while acting as a Global Project Director/Manager in Europe, South America, North America, Africa and Asia Pacific/Australia. Thomas obtained his PhD in Cell Biology from Humboldt University Berlin (Germany), a diploma in Oncology from Max Delbruck Center for Molecular Medicine (MDC) and a Master’s degree in Biochemistry from Humbolt-Universitat zu Berlin.

Dr Iwona Kmicikiewicz

Head of Pharmacovigilance Department / Office Director

Dr Iwona Kmicikiewicz

Head of Pharmacovigilance Department / Office Director

Dr. Iwona Kmicikiewicz, of Kraków Poland obtained her PhD in Biology from Jagiellonian University (Kraków), with specialization in endocrinology. She served in the capacity of a Pharmacovigilance Department Safety Officer and as a local QPPV in a pharmaceutical company with portfolio of over 100 different products registered in over 40 markets for over nine years. She was engaged in the set-up and maintenance of the safety system with SOP development, preparation, training of staff, processing and reporting activities. Since 2000 she has worked as Project Manager mainly responsible for bioequivalence studies.

Since 2004, Dr. Kmicikiewicz has worked in the capacity of Safety Manager and Project Manager in Ergomed. With 18 years of clinical trial experience she has participated in or led a wide variety of phase II – III multi-centre / multi-national clinical research programmes and large scale trials. Starting in 2008, Dr. Kmicikiewicz was key in the set-up of Primevigilance providing for both clinical and post-registration safety services. Since 2011, she has taken the role of Manager of Clinical Operations in Ergomed Krakow office, with responsibility for leading clinical operations in Poland and the related countries. Beginning in 2013, she has served in the capacity of a Head of the Clinical Safety Department, Project Director and Office Director in Ergomed Polish office.

Dr Shazia Rahman

Head of HR and Resourcing

Dr Shazia Rahman

Head of HR and Resourcing

Dr Shazia Rahman is Ergomed’s Head of HR and Resourcing and she has been with the organization since September 2016. With over 20 years of clinical research experience in clinical operations and resource management, Shazia’s background and insight allows for Ergomed to attract the most qualified team members the industry has to offer. Shazia obtained her Doctorate of Philosophy, Medicinal Chemistry from the University of Sussex, UK.